T1	Participants 383 399	patients with HF
T2	Participants 496 655	1457 patients enrolled in the Controlled Rosuvastatin Multinational Trial in HF (CORONA) and 1233 patients enrolled in the GISSI-Heart Failure trial (GISSI-HF)
#1	AnnotatorNotes T2	Participants were from this study.
T3	Participants 1715 1739	patients with chronic HF
